---
type: validation
section: 2 (v2 — Group-wide capital-allocation draft)
target: vault/Projects/Business_Plan_Drafts_v2/Section_02_Business_Description.md
pipeline_stage: Independent Pass 2 QA review (per bp-orchestrator.md "Known runtime constraint" — a
  section may not be marked unqualified "Done" until it passes a genuinely separate Pass 2 review)
run_date: 2026-07-24
reviewer: independent Pass 2 reviewer (fresh thread, no memory of drafting)
result: PASS WITH MINOR FIXES
---

# QA & Final Review — Section 2 (Business Description), Independent Pass 2

## Independence statement
Fresh thread, no memory of any drafting conversation. Everything below is derived from reading files
already on disk: the Section 2 draft, `AI_Business_Plan_Template.md`, `.claude/skills/qa-review/SKILL.md`,
`.claude/skills/business-plan-drafting/SKILL.md`, `.claude/skills/citation-audit/SKILL.md`,
`Problem_Charter.md`, `vault/Architecture/Geographic_Evidence_Rules.md`, the three 2026-07-23 gate
templates, `DEC-008`, `DEC-009`, `Assumptions_Register.md`, `Investment_Portfolio_Register.md`, and the
full set of underlying Facts/Topics/Sources notes the section cites. My own citation audit
(`Citation_Audit_Section_02_v2_Pass2.md`) is the evidentiary basis for checklist item 3 below.

## 1. Template completeness
Checked every required sub-bullet in `AI_Business_Plan_Template.md` §2:

| Required sub-bullet | Present? |
|---|---|
| Industry overview and opportunities for AI adoption | Yes — §2.1 |
| Problem statement, decomposed MECE into root drivers | Yes — §2.2, four sub-problems |
| Governing hypothesis ("We believe [X] will [Y] because [Z]") | Yes — §2.3, matches the required form |
| Core features and benefits | Yes — §2.4, five features with a closing "Benefit, stated plainly" |
| Business model | Yes — §2.5, explicitly selects "internal capability" |
| Current business stage | Yes — §2.6, distinguishes Group maturity from the specific capability's pilot-appropriate stage |

**No required sub-bullet is missing. Template-complete.**

## 2. McKinsey Lens

- **Pyramid Principle:** Pass. "Answer, stated first" states the full conclusion (apply an
  evidence-ranked, stage-gated framework to the already-approved USD175mn envelope) in the first
  paragraph, before any supporting detail.
- **MECE (§2.2):** Pass, and the section states explicitly why: every dollar falls into exactly one of
  cross-bucket / within-bucket-cross-initiative / cross-market / timing-and-staging, with no overlap
  and no gap named. I independently traced this against `Investment_Portfolio_Register.md` and found
  no fifth category the decomposition misses.
- **Hypothesis-driven (§2.3):** Pass. The governing hypothesis is stated in the required form and is
  honestly scoped — it explicitly disclaims reverse-engineering talabat's actual allocation logic, which
  is itself faithful to `Capital Allocation and Investment Governance.md`'s central finding (the corpus
  discloses outputs, not mechanics).
- **Value-driver traceability:** Section 2 correctly hands off to Section 4 (mechanisms), Section 9
  (financial case, bounded by DEC-008), and Section 13 (monitoring) — consistent language, no
  contradiction with what I found reading Section 4 in parallel for this same review cycle.

## 3. Citation audit consumption
Read my own `Citation_Audit_Section_02_v2_Pass2.md` in full (re-derived independently, not trusting the
Pass-1 self-check). **No hard citation failures.** One real, actionable finding: §2.4's claim that
`ASM-015`–`028` are "held to `Proposed` status pending human approval" is now stale — these rows are
confirmed `Approved` in `Assumptions_Register.md` as of 2026-07-23, and the section's prose was never
updated to reflect this (unlike the DEC-009 status, which *did* receive a correct same-day Addendum).
One persisting minor formatting gap: `TLB-025` citations lack a page number.

**Neither finding is an open citation failure under the citation-audit skill's own rules** (nothing
resolves to an untraceable claim or a genuinely-still-Proposed assumption) — so per the qa-review
skill's rule 3 ("any open failure blocks approval outright"), there is no blocking failure here. Both
findings are currency/formatting fixes, correctly classified as PASS WITH MINOR FIXES rather than FAIL.

## 4. Staleness check
- `Topics/AI.md`, cited in §2.5, still carries stale pre-pivot language in its own "Why It Matters" and
  "Business Implications" sections ("For an Egypt-focused retention strategy..."; "the capstone can
  recommend that talabat Egypt's next data investment..."). Section 2 does not cite or rely on those
  stale sentences specifically — it draws only on the note's Overview (the Delivery Hero-inheritance
  fact) — but the note itself has not been refreshed for the Group-wide problem. **Acknowledged and
  flagged for research-agent re-verification, not a Section 2 defect** (this was also flagged, correctly,
  by the Pass-1 citation audit).
- All other cited Topic/Facts notes (`GMV.md`, `Capital Allocation and Investment Governance.md`,
  `2026 Investment Programme.md`, `Marketplace_Facts.md`, `Countries.md`) are current, dated 2026-07-23,
  and built specifically for this pivot.
- `Value_Driver_Tree_v2.md` and `KPI_Tree_v2.md` are current-session forecast-layer artifacts, not
  stale research notes.

## 5. Anti-patterns checklist (against `.claude/skills/business-plan-drafting/SKILL.md`)
- **Untraceable claim:** None found. **Pass.**
- **Group/GCC figure presented as Egypt-specific without an inference qualifier:** Not found — Section 2
  is almost entirely Group-level and correctly labeled as such throughout. **Pass.**
- **"MENA" as a stand-in for the 8-market footprint:** Not used anywhere in Section 2. **Pass.**
- **Showing the 2.2:1 Everyday App:Food-leadership split as a quantified exhibit:** Not done — Section 2
  states the ~120mn:55mn split as the disclosed constraint (problem 1 of the MECE decomposition), never
  as a ranked financial sub-case. **Pass.**
- **Citing an Assumption row's status incorrectly:** **Partial fail** — see finding above (§2.4's
  ASM-015–028 status claim is stale). This is exactly the anti-pattern the drafting skill names
  explicitly ("Citing an Assumption Register row's status incorrectly — check `Assumptions_Register.md`
  directly rather than assuming"). Needs the fix identified in the citation audit.
- **Presenting a country-level allocation split as if disclosed:** Not done. **Pass.**
- **Showing ASM-029–033 dollar ranges as a headline commitment, or omitting the mandatory DEC-009
  disclosure sentence:** Not applicable — Section 2 shows no dollar ranges for OPT-001–005 at all,
  narrative-only throughout. **Pass.**
- **Refusing to state a recommended funding sequence at all:** Section 2 does not itself state the
  DEC-009 funding sequence (OPT-002/003 near-term, OPT-001/005 continue-at-pace, OPT-004 longer-horizon)
  — but per the drafting skill's own section map, that commitment is explicitly assigned to **Section
  9/12**, not Section 2 (whose job is problem decomposition, hypothesis, and business-model framing).
  Section 2's own provenance-note Addendum flags this as something "a future drafting/QA pass should
  confirm" is handled correctly in Section 9/12 — I read this as an appropriately scoped forward pointer,
  not a Section 2 defect. **Not applicable / correctly out of scope for this section.**
- **Representing the OS's recommendation as an automatic management decision:** Not applicable to
  Section 2's content. **Pass.**
- **Resolving a flagged gap silently instead of routing through Research/Forecast/Decision:** Not done —
  the cross-market allocation gap (problem 3) is named openly and explicitly deferred, not resolved
  silently. **Pass.**

## 6. Problem Consistency Gate

| # | Check | Result | Evidence |
|---|---|---|---|
| 1 | Matches `Problem_Charter.md` in substance | Pass | Section 2's Answer and MECE decomposition are the USD175mn Everyday App/Food-leadership allocation question, verbatim in substance |
| 2 | Geographic scope matches charter | Pass | Eight-market Group scope stated in §2.1; no "MENA" usage |
| 3 | Decision question matches charter | Pass | §2.2/§2.3 frame the decision as allocation, not retention |
| 4 | Investment envelope matches disclosed figures, no invented sub-splits presented as disclosed | Pass | ~120mn/~55mn stated as disclosed fact; OPT-level ranges never appear in Section 2 at all |
| 5 | Evidence-category discipline respected (Facts/inferences/Decisions/Assumptions/Forecasts/synthetic never blended) | Pass | Section consistently distinguishes disclosed facts from its own governing hypothesis and from DEC-009's analytical rankings |
| 6 | Output requirements match charter (ranges/scenarios/staged funding, not false precision) | Pass | §2.6 explicitly quotes the charter's own "cannot be proven from public data alone" framing |
| 7 | No active file cited as if current when superseded | Pass | The `supersedes_note` correctly marks the pre-pivot Section 2 draft as historical/untouched; no pre-pivot `DEC-`/`ASM-` row is cited |
| 8 | Any pre-pivot reference clearly marked historical | Pass | The provenance note's "at drafting time, DEC-009 (status: proposed)" is correctly kept in past tense, with the Addendum layering the current status; no unmarked pre-pivot residue found |

**Verdict: PASS (8/8).**

## 7. Financial Integrity Gate (Section 2 touches financial figures but is not a primary financial-bearing section per the gate template's own scope note — run at reduced but real applicability)

| # | Check | Result | Evidence |
|---|---|---|---|
| 1 | Allocation totals reconcile | Pass | 120+55=175, stated and consistent throughout |
| 2 | Scenario arithmetic consistent | N/A | Section 2 builds no scenario exhibit |
| 3 | Units consistent within each exhibit | Pass | No mixing found (USD millions vs. GMV-percentage-points kept separate: "~USD120mn / ~0.7pp" style pairing is always both-stated, not substituted) |
| 4 | Currency stated and consistent | Pass | USD throughout |
| 5 | Time periods stated, not silently mixed | Pass | FY2024 GMV, FY2025 EBITDA margin, and the FY2026 guided bridge are each correctly dated and never blended |
| 6 | Percentage logic correct | Pass | GMV-percentage-point figures (~0.7pp/~0.5pp) never confused with percentage-of-revenue |
| 7 | No double counting | Pass | No overlapping figures counted twice |
| 8 | No additive stacking of overlapping uplift statistics | N/A | Section 2 does not cite uplift statistics (that's Section 4's job) |
| 9 | Revenue/GMV/gross profit/EBITDA not mixed | Pass | Each named distinctly and correctly (GMV 7,428mn; EBITDA margin 6.5%/6.0%→4.6%) |
| 10 | No unlabeled false precision | Pass | Every figure is either a disclosed fact with citation or explicitly labeled "narratively, not quantified" for the 2.2:1/DEC-009 material |
| 11 | DEC-008 respected (no quantified 2.2:1 sub-case) | Pass | Section 2 never shows the 2.2:1 split as a number — only as the disclosed ~120mn:55mn bucket split, which is different from, and does not violate, DEC-008's restriction on the *illustrative GMV-effect* ratio (`ASM-018`) |

**Verdict: PASS (all applicable checks).**

## 8. Geographic Evidence Gate

| # | Check | Result | Evidence |
|---|---|---|---|
| 1 | Every numeric/directional claim geography-tagged | Pass | All Group-level figures identified as such in the traceability table and prose |
| 2 | No Group/GCC figure presented as Egypt-specific | Pass | Confirmed by independent re-check |
| 3 | No Egypt-specific figure presented as Group-representative | Pass | No Egypt-specific figure appears in Section 2 at all |
| 4 | Pre/post-FY2025 non-GCC figures not used interchangeably | N/A | Section 2 does not cite a non-GCC figure |
| 5 | Time period of every geography-tagged claim stated and matches source | Pass | FY2024/FY2025/FY2026 figures each correctly dated |
| 6 | No unsupported metric transfer | Pass | None found |
| 7 | Every inferred-applicability claim explicitly labeled | Pass | Egypt's role via OPT-002 is framed only as a candidate initiative name, not an inference-bearing statistic |
| 8 | "MENA" never used as a stand-in | Pass | Not used |
| 9 | External figures not blended with talabat's own without reconciliation | N/A | No external market-research figures cited in Section 2 |

**Verdict: PASS (9/9 applicable).**

## Result
**Section 2 (Business Description): PASS WITH MINOR FIXES.**

Template-complete, Pyramid-first, MECE with an independently-confirmed rationale, genuinely
hypothesis-driven, clean on all three new gates, and free of hard citation failures. **Two fixes are
required before this section should be marked ✅ Done, neither of which requires new drafting or
re-argumentation:**

1. **§2.4:** update "held to `Proposed` status pending human approval" to reflect that `ASM-015`–`028`
   are now `Approved` (per `Assumptions_Register.md`, resolved 2026-07-23) — the same kind of
   currency-update the section's DEC-009 Addendum already correctly performed for a different
   dependency.
2. **§2.1, §2.6, and the traceability table:** add a page number to the two `TLB-025` citations (e.g.,
   `TLB-025, page 1`) to close the last formatting gap the Pass-1 audit's recommended fix did not fully
   apply.

Both are narrow, mechanical edits. I am not making them myself (Read/Grep/Write only, and this review's
role is to approve or reject, not rewrite prose) — handing them back to the Orchestrator. I am not
flipping the section's frontmatter `status` or the Project tracker's status cell myself.

## Links
- `.claude/skills/qa-review/SKILL.md`, `.claude/skills/citation-audit/SKILL.md`
- [[Section_02_Business_Description]]
- `vault/Validation/Citation_Audit_Section_02_v2_Pass2.md` (this review's evidentiary basis)
- `vault/Validation/Citation_Audit_Section_02_v2.md` (Pass-1 self-check, read for context)
- `DEC-008`, `DEC-009`, `vault/Decisions/Assumptions_Register.md`
